Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection : a case report
Copyright © 2024 Vita, D’Abramo, Coppola, Farroni, Iori, Faraglia, Sette, Grifoni, Lindestam Arlehamn, Bibas, Goletti and Nicastri..
Here we describe the case of a 51 years old Italian woman with acute lymphoblastic leukemia who underwent to hematopoietic stem cell transplantation (HSCT) during SARS-COV-2 infection. She presented a prolonged COVID-19 successfully treated with dual anti SARS-COV-2 antiviral plus monoclonal antibody therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Frontiers in oncology - 14(2024) vom: 16., Seite 1290614 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vita, Serena [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antigen-specific response |
|---|
| Anmerkungen: |
Date Revised 29.02.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fonc.2024.1290614 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369046684 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369046684 | ||
| 003 | DE-627 | ||
| 005 | 20240229235443.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fonc.2024.1290614 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1311.xml |
| 035 | |a (DE-627)NLM369046684 | ||
| 035 | |a (NLM)38414746 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Vita, Serena |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection |b a case report |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 29.02.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2024 Vita, D’Abramo, Coppola, Farroni, Iori, Faraglia, Sette, Grifoni, Lindestam Arlehamn, Bibas, Goletti and Nicastri. | ||
| 520 | |a Here we describe the case of a 51 years old Italian woman with acute lymphoblastic leukemia who underwent to hematopoietic stem cell transplantation (HSCT) during SARS-COV-2 infection. She presented a prolonged COVID-19 successfully treated with dual anti SARS-COV-2 antiviral plus monoclonal antibody therapy | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a HSCT | |
| 650 | 4 | |a SARS-CoV-2 infection | |
| 650 | 4 | |a antigen-specific response | |
| 650 | 4 | |a antivirals | |
| 650 | 4 | |a dual antiviral therapy | |
| 650 | 4 | |a immunocompromised | |
| 650 | 4 | |a prolonged infection | |
| 700 | 1 | |a D'Abramo, Alessandra |e verfasserin |4 aut | |
| 700 | 1 | |a Coppola, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Farroni, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Iori, Anna Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Faraglia, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Sette, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Grifoni, Alba |e verfasserin |4 aut | |
| 700 | 1 | |a Lindestam Arlehamn, Cecilia |e verfasserin |4 aut | |
| 700 | 1 | |a Bibas, Michele |e verfasserin |4 aut | |
| 700 | 1 | |a Goletti, Delia |e verfasserin |4 aut | |
| 700 | 1 | |a Nicastri, Emanuele |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in oncology |d 2011 |g 14(2024) vom: 16., Seite 1290614 |w (DE-627)NLM218189583 |x 2234-943X |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2024 |g day:16 |g pages:1290614 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fonc.2024.1290614 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2024 |b 16 |h 1290614 | ||